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ABSTRACTS 
PREDICTOR OF ~ORT~~~~ TM PATlElJTS 
TH ACUTE M!!OCARD INFARCTION? 
Michael W. Rich, Matthew S. Bosx~e~~ na K. ung 9 Jason 
Sheno John P. McKenzie, Jewish spital at Washington 
Uniwereity MzdicaP Center, Se. UiS$ MO 
vanced age Pe associated incxeased mortditv 
SURVIVAL AFTER ACUTE YOCARDIAL INFARCTION IN PATIEPiTS 70 
YEARS AND OLDER 
Richard 3. Backes, Eric G. Tangalos, Bernard 3. Gersh, 
Thoma<-E Kottke, Mayo Clinic and Mayo Foundation, 
Rocheste;, innesota 
The last decade has been associated 
decline in case-fatality rates of yo 
hospitalized for treatment of acute myocardial infarction 
(MI). To exam%le whether pts. aged 70 and older shared 
this same experience, e abstracted the records of all 
Olmsted County pts. ag were hospit;? 
ized at Mayo Clinic hospitals for acut I and treated in 
the coronary care unit in 1976-78 (n = 1 and 1987-89 (n 
= 190). 
Survival rates to discharge from the CCU were only 
slightly better in the 1980s compared to the 1970s (75 
Probability of survival at one aIlL: two 
tween the earlier and lat 
at one year and 46% vs 53 
Increasing intensity of therapy for acute 
elderly is associated with only marginal increases in 
short-term survival and did not increase long-term 
survival in this population. 
Or;, Daniel Levy. 
UTOMATIC IMPLANTABLE 
iana Aarons, Juan Juante y, Enrico P. Veltri. 
f Baltimore, Baltimore, A 
atic implantable cardioverter-defibrillator (AICW) 
in patients at higk risk for sudden cardiac death 
(SCD). No previous study has reported its specific use in the 
elderly. We sompared the consecutive AlCD experience of 20 
elderly patients (age ~70 yrs) (Group I) to 30 young pat;ents 
(45 40 yrs) (Group II). Group I consisted of 17 males, mean 
age 76 (70-M); coronar 
ejection fraction 35%. 
variables other than age 
implan?, Group I had failed greater dr 
haa .xclre programmed stimulation (PS) trials (mean 4.6 vs 1 7). 
had Iongel hospital stay (mean 34 vs 22 days), and longer time 
from first PS pi implane (mean 18 vs 13 days) (all p &OS). 
Four of 20 (20%) Croup I patients vs none of Groul; II 
required concomitant pacemaker. There were no significant 
differences in operative mortality or complica!ions. or post- 
operative intensive care or progressive care days. Readmissions 
for arrhythmic events occurred in 47% Group I vs 55% Group 
11 (PM;). Appropriate AKW discharges occurred in 35% 
Group I patients and 37% Group I1 patients (p=ns). There was 
CD (7%) in Group i1 ar l-3 
: Elderly patients undergoing 
AICW implantation had longer hospitalization due to pre- 
implant PS drug trials and required greater need for 
concomitant pacemaker compared to younger population; 
operative risk and AiCW efficacy appears comparable. 
